Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells - PubMed (original) (raw)
. 2005 Aug 31;37(4):353-64.
doi: 10.1038/emm.2005.45.
Eun Joung Lim, Moon Young Lee, Jong-Hwan Park, Sang-Kyu Ye, Eui U Park, Sang Yoon Kim, Zheng Zhang, Kwang Jeon Lee, Dong Ki Park, Taekyu Park, Won Kook Moon, Young Mok Yang
Affiliations
- PMID: 16155412
- DOI: 10.1038/emm.2005.45
Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells
Youn Hee Joung et al. Exp Mol Med. 2005.
Abstract
Hypoxia, a common consequence of solid tumor growth in breast cancer or other cancers, serves to propagate a cascade of molecular pathways which include angiogenesis, glycolysis, and various cell-cycle control proteins. As we have shown previously, hypoxia activates STAT5 (signal transducer and activator of transcription 5) and increases its binding activity to the GAS element in mammary epithelial cells. In this study we attempted to elucidate the mechanism by which cyclin D1 is regulated by the STAT5 protein under hypoxic conditions. Our data demonstrate that hypoxia (2% O(2)) or desferrioxamine (DFO) induces tyrosine and serine phosphorylation of STAT5 in human breast cancer cells (MCF-7) and mammary epithelial cells (HC11). Imunoprecipitation and subsequent Western analysis showed that Jak2 leads to the tyrosine phosphorylation and activation of STAT5a or STAT5b under hypoxic conditions. Using a transfected COS-7 cell model system, we demonstrate that the activity of a cyclin D1 promoter-luciferase construct increased under hypoxic conditions or DFO treatment. The activity of the STAT5b/cyclin D1 promoter increased significantly by 12 h of hypoxia, whereas the activity of the STAT5a/cyclin D1 promoter was unaffected under hypoxic conditions. These increases in promoter activity are predominantly mediated by the Jak2/STAT5b signaling pathway. We have shown by EMSA that hypoxia induces STAT5 to bind to the cyclin D1 promoter (GAS-1) in MCF-7 and HC11 cells. These data suggest that STAT5b may mediate the transcriptional activation of cyclin D1 after hypoxic stimulation.
Similar articles
- Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
Joung YH, Lim EJ, Kim MS, Lim SD, Yoon SY, Lim YC, Yoo YB, Ye SK, Park T, Chung IM, Bae KY, Yang YM. Joung YH, et al. Int J Oncol. 2008 Sep;33(3):477-84. Int J Oncol. 2008. PMID: 18695876 - PRL activates the cyclin D1 promoter via the Jak2/Stat pathway.
Brockman JL, Schroeder MD, Schuler LA. Brockman JL, et al. Mol Endocrinol. 2002 Apr;16(4):774-84. doi: 10.1210/mend.16.4.0817. Mol Endocrinol. 2002. PMID: 11923474 - Hemin inhibits cyclin D1 and IGF-1 expression via STAT5b under hypoxia in ERalpha-negative MDA-MB 231 breast cancer cells.
Lim EJ, Joung YH, Jung SM, Park SH, Park JH, Kim SY, Hwang TS, Hong DY, Chung SC, Ye SK, Moon ES, Park EU, Park T, Chung IM, Yang YM. Lim EJ, et al. Int J Oncol. 2010 May;36(5):1243-51. doi: 10.3892/ijo_00000608. Int J Oncol. 2010. PMID: 20372799 - Examining the role of cyclin D1 in breast cancer.
Velasco-Velázquez MA, Li Z, Casimiro M, Loro E, Homsi N, Pestell RG. Velasco-Velázquez MA, et al. Future Oncol. 2011 Jun;7(6):753-65. doi: 10.2217/fon.11.56. Future Oncol. 2011. PMID: 21675838 Review. - Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis.
Knowles HJ, Harris AL. Knowles HJ, et al. Breast Cancer Res. 2001;3(5):318-22. doi: 10.1186/bcr314. Epub 2001 Jul 17. Breast Cancer Res. 2001. PMID: 11597321 Free PMC article. Review.
Cited by
- Oncogenic and Tumor Suppressive Components of the Cell Cycle in Breast Cancer Progression and Prognosis.
Kashyap D, Garg VK, Sandberg EN, Goel N, Bishayee A. Kashyap D, et al. Pharmaceutics. 2021 Apr 17;13(4):569. doi: 10.3390/pharmaceutics13040569. Pharmaceutics. 2021. PMID: 33920506 Free PMC article. Review. - PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.
Jarrar MH, Baranova A. Jarrar MH, et al. J Cell Mol Med. 2007 Jan-Feb;11(1):71-87. doi: 10.1111/j.1582-4934.2007.00003.x. J Cell Mol Med. 2007. PMID: 17367502 Free PMC article. Review. - Transcriptional regulation of the cyclin D1 gene at a glance.
Klein EA, Assoian RK. Klein EA, et al. J Cell Sci. 2008 Dec 1;121(Pt 23):3853-7. doi: 10.1242/jcs.039131. J Cell Sci. 2008. PMID: 19020303 Free PMC article. Review. No abstract available. - Apoptosis-associated speck-like protein containing a CARD regulates the growth of pancreatic ductal adenocarcinoma.
Koizumi M, Watanabe T, Masumoto J, Sunago K, Imamura Y, Kanemitsu K, Kumagi T, Hiasa Y. Koizumi M, et al. Sci Rep. 2021 Nov 16;11(1):22351. doi: 10.1038/s41598-021-01465-2. Sci Rep. 2021. PMID: 34785680 Free PMC article. - The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts.
S P N, Darvin P, Yoo YB, Joung YH, Kang DY, Kim DN, Hwang TS, Kim SY, Kim WS, Lee HK, Cho BW, Kim HS, Park KD, Park JH, Chang SH, Yang YM. S P N, et al. BMC Cancer. 2015 Jun 19;15:474. doi: 10.1186/s12885-015-1445-0. BMC Cancer. 2015. PMID: 26084564 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous